HCV NS5B polymerase nucleotide inhibitors (Merck)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHCV NS5B polymerase nucleotide inhibitors (Merck)
Drug Alias NameHCV NS5B polymerase nucleotide inhibitors (Idenix)4-TPLNA-G-TP
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIdenix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncIdenix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A